A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
age
analogue
anticipated
assigned
Asymptomatic
blinded
bpm
Characteristics
clinical trial
comparator
components
Contact
Controlled trial
coronavirus disease
COVID-19
COVID-19 symptom
COVID19
Date
deficiency
develop
Diabetes Mellitus
Diagnosis
disease
dissemination
dose
double-blind
drug
Efficacy
Efficiency
eight
element
enrolled
enrolment
EU Clinical Trial
evaluate
evaluate the effect
exclusion criteria
experimental arm
female participant
Final
Glucose
haloperidol
healthcare
healthcare worker
Healthcare workers
hematological
Hemodialysis
hepatitis B
Hereditary
high risk
history
HIV
HIV infection
hospital
hypersensitivity
IgM/IgG
immune
immunosuppressive
incidence
Inclusion
Infection
Inflammatory cytokine
Intervention
less
lymphopenia
male
melatonin
men and women
multicenter
myasthenia gravis
number
objective
outcome
participant
Patient
PCR
Placebo
polymerase chain
post-symptom onset
Premenopausal
Prevent
prophylactic treatment
Prophylaxis
protocol
Ramón
randomisation
randomised
randomised controlled trial
randomization
Randomized
Rapid test
receiving
recruited
renal failure
Research
Retinitis
rheumatoid arthritis
risk
RT-PCR
Sample size
SARS-CoV 2
SARS-CoV-2
SARS-COV-2 infection
SAS version 9.4
secondary
sequence
Seroconversion
severe COVID-19
severity of COVID-19
Sex
Spain
Spanish
statistical
status
stratified
study drug
Study protocol
symptomatic infection
symptomatic SARS-CoV-2 infection
Treatment
Trial
two-arm parallel
ulcerative colitis
understanding
urinary pregnancy test
Vasculitis
website
weight
women
[DOI] 10.1186/s13063-020-04436-6 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04436-6 PMC 바로가기 [Article Type] Letter